We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Warning on Faulty Implanted Defibrillators

By HospiMedica staff writers
Posted on 29 Jun 2005
Certain implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices develop an internal short circuit without warning, resulting in failure to deliver a shock when needed. More...
The manufacturer, Guidant Corp. (Indianapolis, IN, USA), is advising doctors worldwide of this development so they can decide how best to treat their patients.

The devices involved are the Ventak Prizm 2DR (model 1861) ICDs manufactured on or before April 16, 2002; the Contak Renewal (model H135) and Contak Renewal 2 (model H155), manufactured on or before August 26, 2004; and the Ventak Prizm AVT, Vitality AVT, Renewal 3AVT, and Renewal 4 AVT ICSs (all series).

The Prizm 2 and Renewal devices are subject to failures that result in the inability to deliver an electric shock during episodes of arrhythmia, which could lead to a serious, life-threatening event for a patient. Twenty-eight reports of failure have been reported worldwide in the Ventak Prizm 2 DR devices, including one death. Fifteen reports of failure mode have been confirmed in the Contak Renewal devices. Two deaths suspected to be associated with this malfunction have been reported to the U.S. Food and Drug Administration (FDA, Washington, DC, USA; www.fda.gov). Guidant recommends that doctors of patients with these devices should continue with normal follow-up visits at three-month intervals. If a decision is made to replace a device, Guidant will provide a replacement at no charge.

In addition, the company's Ventak Prizm AVT, Vitality AVT, Renewal 3 AVT, and Renewal 4 AVT devices are subject to a memory error, which may affect available therapy. Guidant is recommending a programming change that can reduce the risk of this happening, a change that can be implemented at the next office visit a patient makes.

The FDA is considering this action of Guidant as a recall and is not making any recommendations at this time on whether individual patients who have one of the devices should have it removed and replaced. That is a decision that should be made by patients in consultation with their doctors. If patients feel an electrical shock from their device or hear an audible "beeping,” they should immediately contact their doctor.




Related Links:
Guidant

Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
X-Ray Generator
Advantage Plus Generators
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.